Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Valsartan/HCT in mild hypertension and organ damage
NCT00687206Phase 4Completed
- Sponsor
- University of Naples Federico II
- Start
- Mar 2008
- Primary completion
- May 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of valsartan and hydrochlorothiazide in hypertension (HTN) and ventricular remodeling (VR), sponsored by University of Naples Federico II. Primary endpoint: Blood Pressure Control at 6 months. Started Mar 2008; status: completed.
02
Drugs
valsartanhydrochlorothiazide
03
Conditions
hypertension (HTN)ventricular remodeling (VR)
Beyond the preview
Go deeper on NCT00687206.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00687206.